Chelation therapy and cancer

Chelation therapy and cancer

Cancer researchers are always looking for new and more effective ways to fight the disease, so it is only natural that they occasionally "loan" treatments from other disciplines to prove their effectiveness in the fight against cancer. Chelation therapy is a form of treatment originally used to combat heavy metal poisoning. While it is very effective in doing that, it has not yet proved effective in providing similar results in the fight against cancer. Chelation therapy Basics It is necessary to understand the fundamentals of chelation therapy to understand why it has proven ineffective in the treatment of cancer. According to the American Cancer Society, chelation therapy is a treatment used to combat cases of lead poisoning. The therapy involves the application of chemicals in the bloodstream to bind heavy metal molecules, which prevents them from binding with the molecules normally present in the body, thus relieving the possibility of toxicity resulting from overexposure to these metals With regard to its proposed use as a treatment for cancer, advocates argue that therapy can act on the elimination of environmental toxins that cause cancer of the blood, as well as metals. Chelation therapy cost is not much high. Chelation and Test Process Chelation therapy is performed by repeated intravenous injections over the course of several hours during the day, which is repeated several times during a cycle of 10 to 12 weeks. The main chemical that is used in the process of chelation therapy with EDTA is called, an artificial chemical created for the first time in Germany during the 1930s. According to the ACS, there are zero studies that demonstrate the effectiveness of the therapy of chelation in the fight against cancer. Although there have been a series of small studies that try to prove their effectiveness, either the result has been minimal or is not present to a significant degree. Despite its current apparent lack of effectiveness, studies on the subject are still ongoing,